Recent advances in improved efficacies of gold nano-formulations in treatment of skin cancer: a systematic review
- PMID: 39833557
- DOI: 10.1007/s00403-025-03817-8
Recent advances in improved efficacies of gold nano-formulations in treatment of skin cancer: a systematic review
Abstract
Skin cancer is the commonest malignancy for the population. Conventional skin cancer treatments include chemotherapy and surgery, but a large number of the chemotherapeutic drugs applied currently have undesirable possessions. The aim of this study is to provide a complete and acute assessment of the antitumor capability of gold nano-formulations in skin cancer as a new and more effectual delivery system for targeted therapy. In this systematic review, we conducted our first search in December 2021. In order to find related studies, 3 databases PubMed, Scopus and ScienceDirect. In order to maintain comprehensiveness in the search, no time limit was considered in the search process and finally the information obtained from the search was transferred to the information management software (EndNote). In order to maximize the number of articles that were related to our topic, a list of references identified in relevant articles was also manually searched and reviewed. Our final search was updated in late December 2021. There was evidence for a correlation between anticancer activities and treatment with gold nano-formulations. Additionally, studies shown that specific functionalization of the gold nanoparticles (Au NPs) which increase targetability to specific populations of cells could increase the application of Au NPs to the effective delivery of drugs to tumor cells. Our study demonstrated that gold nano-formulations are possible candidates for skin cancer treatment and might provide additional support for the clinical use of these anticancer agents in the future.
Keywords: Au NPs; Cancer; GNPs; Melanoma; Nano-targeted therapy.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
A review of small molecules and drug delivery applications using gold and iron nanoparticles.Int J Nanomedicine. 2019 Mar 11;14:1633-1657. doi: 10.2147/IJN.S184723. eCollection 2019. Int J Nanomedicine. 2019. PMID: 30880970 Free PMC article. Review.
-
Gold Nanoparticles for the Delivery of Cancer Therapeutics.Adv Cancer Res. 2018;139:163-184. doi: 10.1016/bs.acr.2018.05.001. Epub 2018 May 24. Adv Cancer Res. 2018. PMID: 29941104 Review.
-
"Gold nanoparticles composite-folic acid conjugated graphene oxide nanohybrids" for targeted chemo-thermal cancer ablation: In vitro screening and in vivo studies.Eur J Pharm Sci. 2017 Jan 1;96:351-361. doi: 10.1016/j.ejps.2016.10.011. Epub 2016 Oct 6. Eur J Pharm Sci. 2017. PMID: 27721039
-
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Eur J Pharm Biopharm. 2015. PMID: 25813885 Review.
-
Nanotechnology approaches in the current therapy of skin cancer.Adv Drug Deliv Rev. 2020 Jan 1;153:109-136. doi: 10.1016/j.addr.2020.02.005. Epub 2020 Feb 27. Adv Drug Deliv Rev. 2020. PMID: 32113956
References
-
- Abotaleb M, Samuel SM, Varghese E, Varghese S, Kubatka P, Liskova A et al (2019) Flavonoids in cancer and apoptosis. Cancers (Basel) 11(1):28 - DOI
-
- Alexis F, Rhee J-W, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC (2008) New frontiers in nanotechnology for cancer treatment. Urologic oncology: seminars and original investigations. Elsevier, pp 74–85
-
- Barar J, Omidi Y (2014) Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer. BioImpacts 4(1):3–14
-
- Liang A, Liu Q, Wen G, Jiang Z (2012) The surface-plasmon-resonance effect of nanogold/silver and its analytical applications. TrAC Trends Anal Chem 37:32–47 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical